Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 218 publications
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.
Journal: Journal for immunotherapy of cancer
Published: February 10, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2025
Genetic haplotypes in VWA8, OSBPL6, and ADAMTS9-AS2 are associated with immune-related adverse effects in ICI-treated patients with cancer.
Journal: Journal for immunotherapy of cancer
Published: September 22, 2025
Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management.
Journal: Frontiers in immunology
Published: August 03, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer.
Journal: Signal transduction and targeted therapy
Published: July 17, 2025
Increasing Cancer Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Journal: bioRxiv : the preprint server for biology
Published: June 03, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Journal: bioRxiv : the preprint server for biology
Published: June 03, 2025
Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications.
Journal: Journal for immunotherapy of cancer
Published: May 05, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.
Journal: Nature communications
Published: February 04, 2025
Last Updated: 09/26/2026